TSP2 promotes IL-6 expression in OASFs

Introduction The degenerative joint disease, osteoarthritis (OA), affects mainly people from middle-age onwards1 and most often…

Eupraxia Pharmaceuticals Inc. Reports Third Quarter 2021 Financial Results | 2021-11-10 | Press Releases

VICTORIA, BC, Nov. 10, 2021 /CNW/ – Eupraxia Pharmaceuticals Inc.(“Eupraxia” or the “Company”) (TSX: EPRX), a…